Entera Bio
ENTX
14 hedge funds and large institutions have $26.7M invested in Entera Bio in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 5 closing their positions.
97% more call options, than puts
Call options by funds: $1.24M | Put options by funds: $628K
0% more funds holding
Funds holding: 14 → 14 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
1.83% less ownership
Funds ownership: 21.53% → 19.7% (-1.8%)
13% less capital invested
Capital invested by funds: $30.6M → $26.7M (-$3.85M)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$3.5M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$82.9K |
| 3 |
Jane Street
New York
|
+$59.3K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$19K |
| 5 |
Morgan Stanley
New York
|
+$16.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$342K |
| 2 |
Verition Fund Management
Greenwich,
Connecticut
|
-$183K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$140K |
| 4 |
Millennium Management
New York
|
-$81.7K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$62K |
ENTX Hedge Fund Activity: Q3 2021 in Review
14 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q3 2021, worth a combined $26.7M — down 13% from $30.6M a quarter earlier.
Fund positioning in ENTX was balanced in Q3 2021: 5 funds opened new positions, 5 closed out, 2 added to existing stakes and 3 trimmed.
The largest buyer was ARK Investment Management, opening a new position worth an estimated $3.5M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $342K sold.
- 14 institutional investors held Entera Bio (ENTX) as of Q3 2021, unchanged from Q2 2021.
- Funds reported $26.7M of Entera Bio stock for Q3 2021, down 13% quarter-over-quarter.
- 5 funds opened new Entera Bio positions in Q3 2021 and 5 closed out, a net change of 0 holders.
- The largest Entera Bio buyer in Q3 2021 was ARK Investment Management, an estimated $3.5M added.
- The largest Entera Bio seller in Q3 2021 was Susquehanna International Group, an estimated $342K sold.
Based on aggregated 13F filings for Q3 2021.